Revere Partners, an institutional venture capital fund that invests at the intersection of health and oral health technology, has announced its return to the Yankee Dental Congress with its fifth consecutive Future of Dentistry Pavilion. The pavilion will highlight emerging technologies influencing the evolution of dental care and advancing medical–dental integration.
Located at Booth #2034, the 2026 Revere Innovation Pavilion will be organized around the theme “Liquid Gold,” with a focus on saliva as an increasingly important diagnostic medium and biological contributor to systemic health and regenerative approaches. The pavilion will include a curated group of early- and growth-stage companies exploring saliva-based applications from clinical, scientific, workflow, and operational perspectives.
“It’s an honor to collaborate once again with the Yankee Dental Congress, as we share a strong mutual interest in accelerating the adoption of dental technology,” said Dr. Jeremy Krell, founder of Revere Partners.
The 2026 Future of Dentistry Pavilion will feature companies applying saliva-related science and technologies to areas such as continuous health monitoring, oral cancer diagnostics, regenerative therapies, and implant stabilization. Participating organizations include:
- HysensBio: Develops regenerative technologies for dentin and periodontal tissues to support biologically driven healing.
- Lura Health: Develops saliva-based diagnostics and continuous monitoring technologies designed to identify disease risk earlier and enable proactive, personalized care.
- OrisDx: Advances diagnostic solutions for early detection of oral cancer using biomarker-driven science.
- RevBio: Develops Tetranite®, a synthetic bone adhesive designed to stabilize dental implants and craniofacial bone structures.
Over the past 5 years, Revere Partners’ presence at the Yankee Dental Congress has served as a forum for introducing clinicians and industry stakeholders to emerging dental and oral-systemic health technologies. “Our goal has always been to provide meaningful exposure to companies driving patient-centered care, solving critical provider care gaps, and propelling medical-dental integration and whole-person care,” added Krell.
